#1 Clinical Trials Search in Europe

Ramipril

Ramipril, an angiotensin-converting enzyme (ACE) inhibitor, has been the subject of numerous clinical trials investigating its efficacy in treating various medical conditions. This article explores the use of Ramipril in different clinical settings, from cardiovascular diseases to neurological disorders, highlighting its potential benefits and safety profile.

Table of Contents

What is Ramipril?

Ramipril is a medication that belongs to a class of drugs called angiotensin-converting enzyme (ACE) inhibitors. It is also known by brand names such as Altace, Tritace, and Delix[1][2]. This medication is primarily used to treat various cardiovascular and kidney-related conditions. Ramipril works by helping to relax blood vessels, which can lower blood pressure and improve blood flow throughout the body.

Conditions Treated with Ramipril

Ramipril is used to treat several medical conditions, including:

  • High Blood Pressure (Hypertension): Ramipril is commonly prescribed to help lower blood pressure in patients with hypertension[3].
  • Coronary Artery Disease: This medication can help reduce the risk of heart attacks and other cardiovascular events in patients with coronary artery disease[1].
  • Heart Failure: Ramipril may be used to improve heart function in patients with heart failure.
  • Diabetic Nephropathy: In patients with type 2 diabetes, Ramipril can help protect the kidneys from damage caused by high blood sugar levels[4].
  • Peripheral Artery Disease: Some studies have shown that Ramipril can improve walking performance in patients with peripheral artery disease[5].

How Ramipril Works

Ramipril works by inhibiting an enzyme called angiotensin-converting enzyme (ACE). This enzyme is responsible for producing a substance called angiotensin II, which causes blood vessels to narrow. By blocking the production of angiotensin II, Ramipril helps blood vessels relax and widen, leading to improved blood flow and lower blood pressure[1].

Additionally, Ramipril may have other beneficial effects on the body, such as:

  • Reducing inflammation in blood vessels
  • Improving the function of the inner lining of blood vessels (endothelium)
  • Protecting organs like the heart and kidneys from damage

Dosage and Administration

Ramipril is typically taken orally in the form of tablets or capsules. The dosage can vary depending on the condition being treated and the individual patient’s needs. Some common dosages include:

  • Starting dose: 2.5 mg once daily
  • Maintenance dose: 5-10 mg once daily
  • Maximum dose: 20 mg once daily

It’s important to note that your doctor will determine the appropriate dosage for you based on your specific condition and how you respond to the medication. Always follow your doctor’s instructions and do not adjust your dosage without consulting them first[1][3].

Potential Benefits of Ramipril

Research has shown that Ramipril can offer several potential benefits for patients with various cardiovascular and kidney-related conditions:

  • Improved Walking Performance: In patients with peripheral artery disease, Ramipril has been shown to improve walking distance and reduce leg pain during exercise[5].
  • Reduced Risk of Cardiovascular Events: Ramipril may help lower the risk of heart attacks, strokes, and other cardiovascular events in high-risk patients[1].
  • Kidney Protection: In patients with diabetes, Ramipril can help slow the progression of kidney damage and reduce the risk of developing end-stage renal disease[4].
  • Improved Endothelial Function: Some studies suggest that Ramipril may help improve the function of the inner lining of blood vessels, which is important for overall cardiovascular health[6].

Side Effects and Safety Considerations

Like all medications, Ramipril can cause side effects in some patients. Common side effects may include:

  • Dizziness
  • Headache
  • Fatigue
  • Dry cough
  • Nausea or stomach upset

More serious side effects, although rare, can include:

  • Angioedema: A potentially serious allergic reaction causing swelling of the face, lips, tongue, or throat
  • Hyperkalemia: High levels of potassium in the blood
  • Acute kidney failure: In rare cases, Ramipril may cause sudden kidney problems

It’s important to discuss any side effects you experience with your doctor. They can help determine if the benefits of the medication outweigh the risks for your specific situation[7].

Ongoing Research and Future Prospects

Researchers continue to study Ramipril to explore its potential benefits in various medical conditions. Some ongoing areas of research include:

  • Cognitive Function: Studies are investigating whether Ramipril can help prevent memory loss in patients with certain types of brain cancer undergoing radiation therapy[8].
  • Alport Syndrome: Research is being conducted to determine if Ramipril can delay kidney failure in children with Alport syndrome, a genetic condition affecting the kidneys[7].
  • Systemic Lupus Erythematosus (SLE): Scientists are exploring whether Ramipril can improve blood vessel function and increase the number of endothelial progenitor cells (cells that help repair blood vessels) in patients with SLE[6].

These ongoing studies may lead to new applications for Ramipril in the future, potentially expanding its use to benefit more patients with various medical conditions.

Aspect Details
Medical Conditions Studied Hypertension, Peripheral Artery Disease, Diabetic Nephropathy, Cognitive Decline in Glioblastoma, Alport Syndrome, Systemic Lupus Erythematosus
Dosage Range 2.5 mg to 10 mg daily, often titrated based on patient tolerance
Administration Oral (tablets or capsules)
Primary Outcomes Measured Blood pressure reduction, walking performance, proteinuria reduction, cognitive function, endothelial function, number of endothelial progenitor cells
Safety Monitoring Hypotension, hyperkalemia, acute renal failure, angioedema
Potential Benefits Improved walking performance in PAD, reduced proteinuria in diabetic nephropathy, potential neuroprotection in glioblastoma patients, improved endothelial function in SLE
Study Designs Randomized controlled trials, open-label studies, crossover studies

FAQ

  • What is Ramipril and how does it work? Ramipril is an angiotensin-converting enzyme (ACE) inhibitor medication. It works by blocking the production of angiotensin II, a substance that narrows blood vessels and increases blood pressure. By reducing angiotensin II, Ramipril helps relax blood vessels, lower blood pressure, and improve blood flow.
  • In which medical conditions is Ramipril being studied? Ramipril is being studied in various medical conditions, including hypertension, peripheral artery disease, diabetic nephropathy, cognitive decline in glioblastoma patients, Alport syndrome in children, and systemic lupus erythematosus. It is also being investigated for its potential to improve endothelial function and increase the number of endothelial progenitor cells.
  • What are some potential benefits of Ramipril observed in clinical trials? Clinical trials have shown potential benefits of Ramipril in improving walking performance in patients with peripheral artery disease, reducing proteinuria in diabetic nephropathy, potentially preventing memory loss in glioblastoma patients undergoing radiation therapy, and improving endothelial function in patients with systemic lupus erythematosus.
  • How is Ramipril typically administered in clinical trials? In clinical trials, Ramipril is typically administered orally, with dosages ranging from 2.5 mg to 10 mg per day. The dosage is often titrated over time, starting with a lower dose and gradually increasing to the target dose based on patient tolerance and study protocol.
  • Are there any specific safety concerns or side effects associated with Ramipril in clinical trials? While Ramipril is generally well-tolerated, clinical trials monitor for potential side effects such as hypotension (low blood pressure), hyperkalemia (high potassium levels), and acute renal failure. In some studies, researchers also assess the incidence of adverse events like angioedema. It's important to note that the safety profile may vary depending on the patient population and specific medical condition being studied.

Ongoing Clinical Trials on Ramipril

  • Study of stopping heart failure medications in patients with non-ischemic cardiomyopathy who responded very well to cardiac resynchronization therapy

    Recruiting

    3 1 1 1
    Investigated drugs:
    Spain

  • A Study Testing Drug Combination for Heart Failure in Women Comparing Increased Doses to Standard Care

    Recruiting

    3 1 1 1
    Investigated drugs:
    Italy

  • Study on the Effects of Sacubitril/Valsartan and Ramipril on Heart Function in Patients with Ischemic Heart Failure with Mid-Range Ejection Fraction

    Recruiting

    3 1 1
    Investigated drugs:
    Poland

  • Study on Controlling Coronary Risk Factors and Platelet Aggregation Using Ramipril, Acetylsalicylic Acid, and Atorvastatin Calcium Trihydrate in Patients with Heart Disease

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Study on Stopping Beta-Blockers in Heart Failure Patients with Recovered Heart Function Using Carvedilol and Drug Combination

    Recruiting

    3 1 1 1
    Investigated drugs:
    France

  • Effect of ramipril, acetylsalicylic acid, and atorvastatin calcium trihydrate plus nurse education on treatment adherence in patients with acute coronary syndrome

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Study on Preventing Heart Disease in Diabetes Patients Using Eprosartan Mesilate and Drug Combination

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Spain

  • Study on Corticosteroids, Dapagliflozin, and Drug Combination for Proteinuria in IgA Nephropathy Patients with Active or Chronic Kidney Lesions

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy

  • Evaluation of the Drug‑Drug Interaction Between Ramipril and Indapamide in Healthy Volunteers

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Czechia

  • A study comparing the absorption of rosuvastatin, amlodipine, and ramipril in healthy men and women.

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia

Glossary

  • Angiotensin-converting enzyme (ACE) inhibitor: A class of medications that work by blocking the production of angiotensin II, a substance that narrows blood vessels and increases blood pressure. ACE inhibitors help relax blood vessels and lower blood pressure.
  • Bioavailability: The extent and rate at which a drug or other substance enters the body's circulation and becomes available at the site of action.
  • Claudication: Pain or cramping in the legs that occurs during exercise or walking, typically caused by inadequate blood flow to the muscles.
  • Endothelial function: The ability of the inner lining of blood vessels (endothelium) to regulate vascular tone, blood clotting, and other important processes. Impaired endothelial function is associated with various cardiovascular diseases.
  • Flow-mediated dilation (FMD): A non-invasive method to assess endothelial function by measuring the dilation of an artery in response to increased blood flow.
  • Glioblastoma: An aggressive type of cancer that occurs in the brain or spinal cord.
  • Microalbuminuria: The presence of small amounts of albumin (a protein) in the urine, which can be an early sign of kidney damage.
  • Peripheral artery disease (PAD): A circulatory condition in which narrowed arteries reduce blood flow to the limbs, typically the legs.
  • Proteinuria: The presence of excess proteins in the urine, which can be a sign of kidney damage or disease.
  • Systemic lupus erythematosus (SLE): A chronic autoimmune disease that can affect various parts of the body, including skin, joints, kidneys, brain, and other organs.

References

  1. https://clinicaltrials.gov/study/NCT03099213
  2. https://clinicaltrials.gov/study/NCT01164761
  3. https://clinicaltrials.gov/study/NCT00841880
  4. https://clinicaltrials.gov/study/NCT04143412
  5. https://clinicaltrials.gov/study/NCT02842424
  6. https://clinicaltrials.gov/study/NCT03979976
  7. https://clinicaltrials.gov/study/NCT01485978
  8. https://clinicaltrials.gov/study/NCT03475186